Literature DB >> 35085523

Aortic Arch Management During Acute and Subacute Type A Aortic Syndromes.

Parth Mukund Patel1, Andy Dong1, Edward Chiou1, Jane Wei2, Jose Binongo2, Bradley Leshnower1, Edward P Chen3.   

Abstract

BACKGROUND: The purpose of this study was to compare the outcomes of no arch intervention, hemiarch replacement, and total arch replacement during type A aortic syndromes in a contemporary series.
METHODS: From 2004 to 2019, 634 patients have required acute type A dissection repair; these patients were divided into three groups based on type of arch intervention performed: no arch (n = 130), hemiarch (n = 397), and total arch (n = 107). The primary endpoint was mortality; a multivariable risk factor analysis was performed. Secondary endpoints were reoperation and early and late complications.
RESULTS: Operative age was 55 ± 14 years for the cohort and was similar between groups (P = .34). The incidence of peripheral artery disease, heart failure, and prior coronary artery bypass graft surgery differed between the groups (P < .05). Median cardiopulmonary bypass time, aortic cross-clamp time, and length of stay were longest for the total arch group (P < .0001). Early mortality was 20%, 10%, and 10% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). Ten-year survival was 54%, 66%, and 65% for the no-arch, hemiarch, and total arch groups, respectively (P = .01). There was no difference in incidence or timing of redo aortic interventions (P > .05). For the entire cohort, risk factors for late mortality included preoperative peripheral artery disease (hazard ratio 2.3; 95% confidence interval, 1.2 to 4.4; P = .009) and preoperative dialysis (hazard ratio 2.8; 95% confidence interval, 1.3 to 6.1; P = .01).
CONCLUSIONS: Despite longer cardiopulmonary bypass and aortic cross-clamp times, arch intervention was not associated with worse operative or long-term outcome in this series. Patients with peripheral vascular disease and preoperative renal failure remain at highest risk for mortality after type A aortic dissection repair.
Copyright © 2022 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2022        PMID: 35085523     DOI: 10.1016/j.athoracsur.2021.12.064

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   5.102


  2 in total

1.  Th1, Th2, and Th17 cells are dysregulated, but only Th17 cells relate to C-reactive protein, D-dimer, and mortality risk in Stanford type A aortic dissection patients.

Authors:  Mowei Song; Li Deng; Hongtao Shen; Guofu Zhang; Hang Shi; Erjun Zhu; Qingping Xia; Hongguang Han
Journal:  J Clin Lab Anal       Date:  2022-05-06       Impact factor: 3.124

2.  Outcomes of hemi- vs. total arch replacement in acute type A aortic dissection: A systematic review and meta-analysis.

Authors:  Likang Ma; Tianci Chai; Xiaojie Yang; Xinghui Zhuang; Qingsong Wu; Liangwan Chen; Zhihuang Qiu
Journal:  Front Cardiovasc Med       Date:  2022-09-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.